PHARMACIELO LTD. ("PCLO") BULLETIN TYPE: Prospectus-Share Offering BULLETIN DATE: July 6, 2020 TSX Venture Tier 1 Company
Effective June 30, 2020, the Company's Prospectus dated June 29, 2020 was filed with and accepted by TSX Venture Exchange, and filed with and receipted by the Ontario, Quebec, Alberta and British Columbia Securities Commission, pursuant to the provisions of the Ontario, Quebec, Alberta and British Columbia Securities Act.
TSX Venture Exchange has been advised that closing occurred on July 3, 2020, for gross proceeds of $4,600,036.80.
Underwrites: Cormark Securities Inc., Stifel Nicolaus Canada Inc. and Echelon Wealth Partners Inc.
Offering: 6,388,940 shares
Share Price: $0.72 per share
Underwriters options: 383,336 non-transferable options exercisable to purchase one common share at $0.72 per share, exercisable until the date that is 24 months following the Closing Date.
________________________________________
|
|